Insiders · NVCT

NVCT insider transactions

Nuvectis Pharma Inc. (NVCT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NVCT

• 106d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 9% to 1,793,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 106d
  Chairman & CEO Bentsur Ron was granted 150,000 shares, increasing direct ownership by 4% to 3,675,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 106d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 9% to 1,806,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 106d
  Vice President, Finance Carson Michael J. was granted 61,200 shares, increasing direct ownership by 44% to 200,118 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 171d
  Chairman & CEO Bentsur Ron bought $28,600 worth of shares (5,000 units at $5.72), increasing direct ownership by 0.14% to 3,525,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 171d
  Director Sanchez Juan bought $75,270 worth of shares (13,000 units at $5.79), increasing direct ownership by 20% to 78,150 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 171d
  Director Kaplan Matthew L. bought $64,240 worth of shares (11,000 units at $5.84), increasing direct ownership by 10% to 124,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 177d
  Director Sanchez Juan was granted 30,000 shares, increasing direct ownership by 85% to 65,150 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 177d
  New insider Sanchez Juan claimed ownership of 35,565 shares (SEC Form 3)

  3 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 179d
  Large owner Mosseri Marlio Charles bought $957,083 worth of shares (154,770 units at $6.18) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 305d
  Large owner Mosseri Marlio Charles bought $44,768 worth of shares (5,603 units at $7.99) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 310d
  Large owner Mosseri Marlio Charles bought $269,532 worth of shares (33,442 units at $8.06) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 317d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 36% to 113,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 317d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 52% to 87,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 317d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 29% to 133,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 347d
  Large owner Mosseri Marlio Charles bought $171,664 worth of shares (21,167 units at $8.11) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 349d
  Amendment: Large owner Mosseri Marlio Charles bought $247,263 worth of shares (27,662 units at $8.94) (SEC Form 4)

  4/A - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 351d
  Large owner Mosseri Marlio Charles bought $235,647 worth of shares (27,411 units at $8.60) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 438d
  Large owner Mosseri Marlio Charles bought $1,200,000 worth of shares (240,000 units at $5.00) (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 477d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 10% to 1,643,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 477d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 10% to 1,656,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 477d
  Vice President, Finance Carson Michael J. was granted 51,000 shares, increasing direct ownership by 58% to 138,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 477d
  Chairman & CEO Bentsur Ron was granted 250,000 shares, increasing direct ownership by 8% to 3,520,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 486d
  Chairman & CEO Bentsur Ron bought $20,925 worth of shares (4,500 units at $4.65), increasing direct ownership by 0.14% to 3,270,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 495d
  Amendment: Large owner Mosseri Marlio Charles bought $228,941 worth of shares (49,121 units at $4.66), increasing direct ownership by 2% to 2,644,121 units (SEC Form 4)

  4/A - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 496d
  Large owner Mosseri Marlio Charles bought $79,900 worth of shares (17,000 units at $4.70), increasing direct ownership by 0.66% to 2,612,000 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 522d
  Chief Science & Business Off Poradosu Enrique bought $9,980 worth of shares (2,000 units at $4.99), increasing direct ownership by 0.13% to 1,506,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 524d
  Chairman & CEO Bentsur Ron bought $98,400 worth of shares (20,000 units at $4.92), increasing direct ownership by 0.62% to 3,266,424 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 533d
  Vice President, Finance Carson Michael J. sold $22,478 worth of shares (2,755 units at $8.16) and was granted 63,373 shares, increasing direct ownership by 222% to 87,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 681d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 56% to 83,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 681d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 41% to 103,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 681d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 108% to 57,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 711d
  Bentsur Ron bought $13,076 worth of shares (1,940 units at $6.74), increasing direct ownership by 0.06% to 3,246,424 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 713d
  Bentsur Ron bought $12,800 worth of shares (2,000 units at $6.40), increasing direct ownership by 0.06% to 3,244,484 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 713d
  Poradosu Enrique bought $3,145 worth of shares (500 units at $6.29), increasing direct ownership by 0.03% to 1,504,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 713d
  Shemesh Shay bought $7,034 worth of shares (1,113 units at $6.32), increasing direct ownership by 0.07% to 1,493,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 768d
  Bentsur Ron bought $51,450 worth of shares (5,000 units at $10.29), increasing direct ownership by 0.15% to 3,242,484 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 841d
  Poradosu Enrique was granted 130,000 shares, increasing direct ownership by 9% to 1,503,819 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 841d
  Shemesh Shay was granted 130,000 shares, increasing direct ownership by 10% to 1,491,955 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 926d
  Bentsur Ron bought $7,091 worth of shares (640 units at $11.08), increasing direct ownership by 0.02% to 3,237,484 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 929d
  Bentsur Ron bought $12,105 worth of shares (1,080 units at $11.21), increasing direct ownership by 0.03% to 3,236,844 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 933d
  Bentsur Ron bought $35,455 worth of shares (3,220 units at $11.01), increasing direct ownership by 0.10% to 3,235,764 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 983d
  SEC Form 4: Bentsur Ron bought $5,112 worth of shares (350 units at $14.61), increasing direct ownership by 0.01% to 3,232,544 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 988d
  SEC Form 4: Bentsur Ron bought $4,418 worth of shares (300 units at $14.73), increasing direct ownership by 0.01% to 3,232,194 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 999d
  SEC Form 4: Mosseri Marlio Charles bought $11,937 worth of shares (860 units at $13.88), increasing direct ownership by 0.03% to 2,595,000 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1000d
  SEC Form 4: Mosseri Marlio Charles bought $35,943 worth of shares (2,584 units at $13.91), increasing direct ownership by 0.10% to 2,594,140 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1003d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1004d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1006d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1006d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1011d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1011d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1012d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1013d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1018d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1019d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1021d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1024d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1024d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1025d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)